342 related articles for article (PubMed ID: 34511884)
1. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment.
Wang K; Miao X; Kong F; Huang S; Mo J; Jin C; Zheng Y
Drug Des Devel Ther; 2021; 15():3749-3764. PubMed ID: 34511884
[TBL] [Abstract][Full Text] [Related]
2. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
3. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.
Guo W; Huang J; Wang N; Tan HY; Cheung F; Chen F; Feng Y
Front Pharmacol; 2019; 10():1185. PubMed ID: 31649545
[TBL] [Abstract][Full Text] [Related]
4. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology.
Shang W; Zhang J; Song H; Zhu S; Zhang A; Hua Y; Han S; Fu Y
Drug Des Devel Ther; 2021; 15():2907-2919. PubMed ID: 34262258
[TBL] [Abstract][Full Text] [Related]
7. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
Wang S; Gao J; Li Q; Ming W; Fu Y; Song L; Qin J
J Ethnopharmacol; 2020 Nov; 262():113189. PubMed ID: 32736044
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
[TBL] [Abstract][Full Text] [Related]
9. Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis.
Wei Y; Ren S; Wang R; Jing M; Liu H; Wang M; Song H; Zhao Y
Evid Based Complement Alternat Med; 2021; 2021():7567025. PubMed ID: 34484403
[TBL] [Abstract][Full Text] [Related]
10. Uncovering the pharmacological mechanism of Wei-Tong-Xin against gastric ulcer based on network pharmacology combined with in vivo experiment validation.
Liu W; Zhang X; Ma T; Wang J; Lv X; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2022 Jul; 293():115282. PubMed ID: 35405254
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
Cao W; Yuan F; Liu T; Yin R
J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
[TBL] [Abstract][Full Text] [Related]
13. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
Gao J; Yang S; Xie G; Pan J; Zhu F
Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
[TBL] [Abstract][Full Text] [Related]
16. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non-small cell lung cancer.
Zeng P; Wang F; Zhang J; Ur Rashid H; Li X; Zhang P; Luo Y; Wu X
Chem Biol Drug Des; 2024 Jan; 103(1):e14414. PubMed ID: 38230796
[TBL] [Abstract][Full Text] [Related]
17. Zuojin Pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis.
Tong Y; Wang R; Liu X; Tian M; Wang Y; Cui Y; Zou W; Zhao Y
J Ethnopharmacol; 2021 May; 271():113893. PubMed ID: 33524511
[TBL] [Abstract][Full Text] [Related]
18. Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence.
Li X; Chen H; Yang H; Liu J; Li Y; Dang Y; Wang J; Wang L; Li J; Nie G
Front Endocrinol (Lausanne); 2022; 13():918469. PubMed ID: 35872979
[TBL] [Abstract][Full Text] [Related]
19. Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer.
Yang PW; Xu PL; Cheng CS; Jiao JY; Wu Y; Dong S; Xie J; Zhu XY
J Ethnopharmacol; 2022 Oct; 297():115516. PubMed ID: 35817247
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]